ARCHIVES

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

AE-941 Shark Cartilage Doesn’t Improve Lung Cancer Survival

May 28, 2010

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

November 24, 1978

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

September 27, 2002

Lenalidomide, An Altered Thalidomide, Shows Promise

November 24, 2006

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

September 10, 1976

NCI Cancer Education Program To Open To Innovative Ideas

April 2, 1993